Current Protein & Peptide ScienceCurrent Protein & Peptide ScienceCurrent Protein & Peptide Science1389-20371875-5550Bentham Science64564710.2174/0113892037278814231226104509Life SciencesResearch ArticleCombating Aminoglycoside Resistance: From Structural and Functional Characterisation to Therapeutic Challenges with RKAATOtunSarahinfo@benthamscience.netGracaRichardinfo@benthamscience.netAchilonuIkechukwuinfo@benthamscience.netDepartment of Molecular and Cell Biology, Protein Structure-function Unit, University of Witwatersrand0106202425645446811012025Copyright ©; 2024, Bentham Science Publishers2024Bentham Science Publishershttps://journals.eco-vector.com/1389-2037/article/view/645647

A comprehensive knowledge of aminoglycoside-modifying enzymes (AMEs) and their role in bacterial resistance mechanisms is urgently required due to the rising incidence of antibiotic resistance, particularly in Klebsiella pneumoniae infections. This study explores the essential features of AMEs, including their structural and functional properties, the processes by which they contribute to antibiotic resistance, and the therapeutic importance of aminoglycosides. The study primarily examines the Recombinant Klebsiella pneumoniae Aminoglycoside Adenylyl Transferase (RKAAT), particularly emphasizing its biophysical characteristics and the sorts of resistance it imparts. Furthermore, this study examines the challenges presented by RKAAT-mediated resistance, an evaluation of treatment methods and constraints, and options for controlling infection. The analysis provides a prospective outlook on strategies to address and reduce antibiotic resistance. This extensive investigation seeks to provide vital insights into the continu

Adenylyl transferaseaminoglycoside antibioticsantibiotic resistancehealthcare-associated infectionsKlebsiella pneumoniaerecombinantKlebsiella pneumoniae Aminoglycoside(3”) (9) adenylyl transferase (RKAAT).Mancuso, G.; Midiri, A.; Gerace, E.; Biondo, C. Bacterial antibiotic resistance: The most critical pathogens. Pathogens, 2021, 10(10), 1310. doi: 10.3390/pathogens10101310 PMID: 34684258Darby, E.M.; Trampari, E.; Siasat, P.; Gaya, M.S.; Alav, I.; Webber, M.A.; Blair, J.M.A. Molecular mechanisms of antibiotic resistance revisited. Nat. Rev. Microbiol., 2023, 21(5), 280-295. doi: 10.1038/s41579-022-00820-y PMID: 36411397Bujotzek, Alexander; Tiefenthaler, Georg; Lariviere, Laurent; D’Andrea, Laura; Marquez, Elsa A.; Rudloff, Ina; Cho, Steven X. Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potential. Cell Chemical Biology , 2022, , 586-596. doi: 10.1016/j.chembiol.2021.10.004Denissen, J.; Reyneke, B.; Waso-Reyneke, M.; Havenga, B.; Barnard, T.; Khan, S.; Khan, W. Prevalence of ESKAPE pathogens in the environment: Antibiotic resistance status, community-acquired infection and risk to human health. Int. J. Hyg. Environ. Health, 2022, 244, 114006. doi: 10.1016/j.ijheh.2022.114006 PMID: 35841823Arcari, G.; Carattoli, A. Global spread and evolutionary convergence of multidrug-resistant and hypervirulent Klebsiella pneumoniae high-risk clones. Pathog. Glob. Health, 2023, 117(4), 328-341. doi: 10.1080/20477724.2022.2121362 PMID: 36089853Kumar, S.; Anwer, R.; Azzi, A. Molecular typing methods & resistance mechanisms of MDR Klebsiella pneumoniae. AIMS Microbiol., 2023, 9(1), 112-130. doi: 10.3934/microbiol.2023008 PMID: 36891535Maione, A.; La Pietra, A.; de Alteriis, E.; Mileo, A.; De Falco, M.; Guida, M.; Galdiero, E. Effect of myrtenol and its synergistic interactions with antimicrobial drugs in the inhibition of single and mixed biofilms of candida auris and klebsiella pneumoniae. Microorganisms, 2022, 10(9), 1773. doi: 10.3390/microorganisms10091773 PMID: 36144375Wyres, K.L.; Lam, M.M.C.; Holt, K.E. Population genomics of Klebsiella pneumoniae. Nat. Rev. Microbiol., 2020, 18(6), 344-359. doi: 10.1038/s41579-019-0315-1 PMID: 32055025Banerjee, T.; Sharma, S.; Rakshit, P. Role of antibiotics in hospital-acquired infections and community-acquired infections. In: Antibiotics - Therapeutic Spectrum and Limitations; Elsevier, 2023; pp. 549-574. doi: 10.1016/B978-0-323-95388-7.00016-4Dhingra, S.; Rahman, N.A.A.; Peile, E.; Rahman, M.; Sartelli, M.; Hassali, M.A.; Islam, T.; Islam, S.; Haque, M. Microbial resistance movements: An overview of global public health threats posed by antimicrobial resistance, and how best to counter. Front. Public Health, 2020, 8, 535668. doi: 10.3389/fpubh.2020.535668 PMID: 33251170Gonzalez-Ferrer, S.; Peñaloza, H.F.; Budnick, J.A.; Bain, W.G.; Nordstrom, H.R.; Lee, J.S.; Van Tyne, D. Finding order in the chaos: Outstanding questions in Klebsiella pneumoniae pathogenesis. Infect. Immun., 2021, 89(4), e00693-20. doi: 10.1128/IAI.00693-20 PMID: 33558323Abbas, Ali Taher; Salih, Hind Abdallah Review of Beta lactams. Ann. Rom. Soc. Cell Biol., 2022, 26, 1863-1881.Albarri, O.; AlMatar, M.; Öcal, M.M.; Köksal, F. Overexpression of efflux pumps acrab and oqxab contributes to ciprofloxacin resistance in clinical isolates of k. pneumoniae. Curr. Protein Pept. Sci., 2022, 23(5), 356-368. doi: 10.2174/1389203723666220630162920 PMID: 35786184AlMatar, M.; Albarri, O.; Var, I.; Köksal, F. Antimicrobial resistance of clinical klebsiella pneumoniae isolates: Involvement of AcrAB and OqxAB Efflux Pumps. Curr. Mol. Pharmacol., 2023, 17(1), e310323215266. doi: 10.2174/1874467217666230331081434 PMID: 36999690Azeredo, J.; García, P.; Drulis-Kawa, Z. Targeting biofilms using phages and their enzymes. Curr. Opin. Biotechnol., 2021, 68, 251-261. doi: 10.1016/j.copbio.2021.02.002 PMID: 33714050Priyanka, A.; Akshatha, K.; Deekshit, V.K. Klebsiella pneumoniae infections and antimicrobial drug resistance. In: In Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery; Singapore: Springer Singapore, 2020; pp. 195-225. doi: 10.1007/978-981-15-1695-5_12Wang, N.; Luo, J.; Deng, F.; Huang, Y.; Zhou, H. Antibiotic combination therapy: A strategy to overcome bacterial resistance to aminoglycoside antibiotics. Front. Pharmacol., 2022, 13, 839808. doi: 10.3389/fphar.2022.839808 PMID: 35281905Dagur, P.; Ghosh, M.; Patra, A. Aminoglycoside antibiotics. In: Medicinal Chemistry of Chemotherapeutic Agents; Elsevier, 2023; pp. 135-155. doi: 10.1016/B978-0-323-90575-6.00009-0Zhang, Yuan; Zhang, Ning; Wang, Mengyu; Luo, Ming; Peng, Yao; Li, Zhenpeng; Xu, Jialiang; Ou, Meiling; Kan, Biao; Li, Xu The prevalence and distribution of aminoglycoside resistance genes. In: Biosafety and Health ; Chinese Medical Journals Publishing House: Dongsi Xidajie, 2023; pp. 14-20.Llano-Sotelo, Beatriz Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site. In: Chemistry & biology; Elsevier, 2002; pp. 455-463.Stern, A.L.; Van der Verren, S.E.; Kanchugal P, S.; Näsvall, J.; Gutiérrez-de-Terán, H.; Selmer, M. Structural mechanism of AadA, a dual-specificity aminoglycoside adenylyltransferase from Salmonella enterica. J. Biol. Chem., 2018, 293(29), 11481-11490. doi: 10.1074/jbc.RA118.003989 PMID: 29871922Wright, Gerard D Aminoglycoside phosphotransferases: Proteins, structure, and mechanism. In: Front Biosci; Citeseer, 1999; pp. 9-21.Sunada, A.; Nakajima, M.; Ikeda, Y.; Kondo, S.; Hotta, K. Enzymatic 1-N-acetylation of paromomycin by an actinomycete strain #8 with multiple aminoglycoside resistance and paromomycin sensitivity. J. Antibiot., 1999, 52(9), 809-814. doi: 10.7164/antibiotics.52.809 PMID: 10726929Hotta, K.; Sunada, A.; Ishikawa, J.; Mizuno, S.; Ikeda, Y.; Kondo, S. The novel enzymatic 3′'-N-acetylation of arbekacin by an aminoglycoside 3-N-acetyltransferase of Streptomyces origin and the resulting activity. J. Antibiot., 1998, 51(8), 735-742. doi: 10.7164/antibiotics.51.735 PMID: 9766465Raslan, M.A.; Raslan, S.A.; Shehata, E.M.; Mahmoud, A.S.; Lundstrom, K.; Barh, D.; Azevedo, V.; Sabri, N.A. Associations between nutrigenomic effects and incidences of microbial resistance against novel antibiotics. Pharmaceuticals, 2023, 16(8), 1093. doi: 10.3390/ph16081093 PMID: 37631008Frase, H.; Toth, M.; Vakulenko, S.B. Revisiting the nucleotide and aminoglycoside substrate specificity of the bifunctional aminoglycoside acetyltransferase(6′)-Ie/aminoglycoside phosphotransferase(2′')-Ia enzyme. J. Biol. Chem., 2012, 287(52), 43262-43269. doi: 10.1074/jbc.M112.416453 PMID: 23115238Ramirez, M.S.; Tolmasky, M.E. Aminoglycoside modifying enzymes. Drug Resist. Updat., 2010, 13(6), 151-171. doi: 10.1016/j.drup.2010.08.003 PMID: 20833577Labby, K.J.; Garneau-Tsodikova, S. Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections. Future Med. Chem., 2013, 5(11), 1285-1309. doi: 10.4155/fmc.13.80 PMID: 23859208Boehr, D.D.; Draker, K.; Koteva, K.; Bains, M.; Hancock, R.E.; Wright, G.D. Broad-spectrum peptide inhibitors of aminoglycoside antibiotic resistance enzymes. Chem. Biol., 2003, 10(2), 189-196. doi: 10.1016/S1074-5521(03)00026-7 PMID: 12618191Baquero, F.; Martínez, J.L.; F Lanza, V.; Rodríguez-Beltrán, J.; Galán, J.C.; San Millán, A.; Cantón, R.; Coque, T.M. Evolutionary pathways and trajectories in antibiotic resistance. Clin. Microbiol. Rev., 2021, 34(4), e0005019. doi: 10.1128/CMR.00050-19 PMID: 34190572Serio, A.W.; Keepers, T.; Andrews, L.; Krause, K.M. Aminoglycoside revival: Review of a historically important class of antimicrobials undergoing rejuvenation. Ecosal Plus, 2018, 8(1), ecosalplus.ESP-0002-2018. doi: 10.1128/ecosalplus.ESP-0002-2018 PMID: 30447062Bennett, C.C. The aminoglycosides. Prim. Care Update Ob Gyns, 1996, 3(6), 186-191. doi: 10.1016/S1068-607X(96)00025-XThacharodi, A.; Lamont, I.L. Aminoglycoside-modifying enzymes are sufficient to make pseudomonas aeruginosa clinically resistant to key antibiotics. Antibiotics, 2022, 11(7), 884. doi: 10.3390/antibiotics11070884 PMID: 35884138Christaki, E.; Marcou, M.; Tofarides, A. Antimicrobial resistance in bacteria: Mechanisms, evolution, and persistence. J. Mol. Evol., 2020, 88(1), 26-40. doi: 10.1007/s00239-019-09914-3 PMID: 31659373Varela, M.F.; Stephen, J.; Lekshmi, M.; Ojha, M.; Wenzel, N.; Sanford, L.M.; Hernandez, A.J.; Parvathi, A.; Kumar, S.H. Bacterial resistance to antimicrobial agents. Antibiotics, 2021, 10(5), 593. doi: 10.3390/antibiotics10050593 PMID: 34067579Munita, J.M.; Arias, C.A. Mechanisms of antibiotic resistance. In: Virulence Mechanisms of Bacterial Pathogens; ASM Press: Washington, DC, USA, 2016; pp. 481-511. doi: 10.1128/9781555819286.ch17Krause, K.M.; Serio, A.W.; Kane, T.R.; Connolly, L.E. Aminoglycosides: An overview. Cold Spring Harb. Perspect. Med., 2016, 6(6), a027029. doi: 10.1101/cshperspect.a027029 PMID: 27252397Martinez, J.L.; Fajardo, A.; Garmendia, L.; Hernandez, A.; Linares, J.F.; Martínez-Solano, L.; Sánchez, M.B. A global view of antibiotic resistance. FEMS Microbiol. Rev., 2009, 33(1), 44-65. doi: 10.1111/j.1574-6976.2008.00142.x PMID: 19054120Winter, M.; Buckling, A.; Harms, K.; Johnsen, P.J.; Vos, M. Antimicrobial resistance acquisition via natural transformation: Context is everything. Curr. Opin. Microbiol., 2021, 64, 133-138. doi: 10.1016/j.mib.2021.09.009 PMID: 34710742Lund, D.; Coertze, R.D.; Parras-Moltó, M.; Berglund, F.; Flach, C.F.; Johnning, A.; Larsson, D.G.J.; Kristiansson, E. Extensive screening reveals previously undiscovered aminoglycoside resistance genes in human pathogens. Commun. Biol., 2023, 6(1), 812. doi: 10.1038/s42003-023-05174-6 PMID: 37537271El-Far, A.; Samir, S.; El-Gebaly, E.; Omar, M.; Dahroug, H.; El-Shenawy, A.; Soliman, N.S.; Gamal, D. High rates of aminoglycoside methyltransferases associated with metallo-beta-lactamases in multidrug-resistant and extensively drug-resistant pseudomonas aeruginosa clinical isolates from a tertiary care hospital in egypt. Infect. Drug Resist., 2021, 14, 4849-4858. doi: 10.2147/IDR.S335582 PMID: 34848977Bassenden, A. Towards structure-guided design of next-generation aminoglycoside antibiotics; McGill University, 2021.Zeiders, S.M.; Chmielewski, J. Antibiotic–cell‐penetrating peptide conjugates targeting challenging drug‐resistant and intracellular pathogenic bacteria. Chem. Biol. Drug Des., 2021, 98(5), 762-778. doi: 10.1111/cbdd.13930 PMID: 34315189Sadovskaya, I.; Vinogradov, E.; Li, J.; Hachani, A.; Kowalska, K.; Filloux, A. High-level antibiotic resistance in Pseudomonas aeruginosa biofilm: The ndvB gene is involved in the production of highly glycerol-phosphorylated -(1->3)-glucans, which bind aminoglycosides. Glycobiology, 2010, 20(7), 895-904. doi: 10.1093/glycob/cwq047 PMID: 20348539Hanberger, H.; Edlund, C.; Furebring, M.; G Giske, C.; Melhus, A.; Nilsson, L.E.; Petersson, J.; Sjölin, J.; Ternhag, A.; Werner, M.; Eliasson, E. Rational use of aminoglycosides--review and recommendations by the swedish reference group for antibiotics (SRGA). Scand. J. Infect. Dis., 2013, 45(3), 161-175. doi: 10.3109/00365548.2012.747694 PMID: 23270477Pagkalis, S.; Mantadakis, E.; Mavros, M.N.; Ammari, C.; Falagas, M.E. Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs, 2011, 71(17), 2277-2294. doi: 10.2165/11597020-000000000-00000 PMID: 22085385Yılmaz, Ç.; Özcengiz, G. Antibiotics: Pharmacokinetics, toxicity, resistance and multidrug efflux pumps. Biochem. Pharmacol., 2017, 133, 43-62. doi: 10.1016/j.bcp.2016.10.005 PMID: 27765485De Oliveira, D.M.P.; Forde, B.M.; Kidd, T.J.; Harris, P.N.A.; Schembri, M.A.; Beatson, S.A.; Paterson, D.L.; Walker, M.J. Antimicrobial resistance in eskape pathogens. Clin. Microbiol. Rev., 2020, 33(3), e00181-19. doi: 10.1128/CMR.00181-19 PMID: 32404435Zhang, J.; Liu, G.; Zhang, X.; Chang, Y.; Wang, S.; He, W.; Sun, W.; Chen, D.; Murchie, A.I.H. Aminoglycoside riboswitch control of the expression of integron associated aminoglycoside resistance adenyltransferases. Virulence, 2020, 11(1), 1432-1442. doi: 10.1080/21505594.2020.1836910 PMID: 33103573Chen, Y.; Näsvall, J.; Wu, S.; Andersson, D.I.; Selmer, M. Structure of AadA from Salmonella enterica : A monomeric aminoglycoside (3′′)(9) adenyltransferase. Acta Crystallogr. D Biol. Crystallogr., 2015, 71(11), 2267-2277. doi: 10.1107/S1399004715016429 PMID: 26527143Roi, A.; Rusu, L.C.; Roi, C.I.; Luca, R.E.; Boia, S.; Munteanu, R.I. A new approach for the diagnosis of systemic and oral diseases based on salivary biomolecules. Dis. Markers, 2019, 2019, 1-11. doi: 10.1155/2019/8761860 PMID: 30906485Qing, R.; Hao, S.; Smorodina, E.; Jin, D.; Zalevsky, A.; Zhang, S. Protein design: From the aspect of water solubility and stability. Chem. Rev., 2022, 122(18), 14085-14179. doi: 10.1021/acs.chemrev.1c00757 PMID: 35921495Tripathi, T.; Dubey, V.K. Advances in protein molecular and structural biology methods; Academic Press, 2022.Pierrat, O.A.; Liu, M.; Collie, G.W.; Shetty, K.; Rodrigues, M.J.; Le Bihan, Y.V.; Gunnell, E.A.; McAndrew, P.C.; Stubbs, M.; Rowlands, M.G.; Yahya, N.; Shehu, E.; Talbot, R.; Pickard, L.; Bellenie, B.R.; Cheung, K.M.J.; Drouin, L.; Innocenti, P.; Woodward, H.; Davis, O.A.; Lloyd, M.G.; Varela, A.; Huckvale, R.; Broccatelli, F.; Carter, M.; Galiwango, D.; Hayes, A.; Raynaud, F.I.; Bryant, C.; Whittaker, S.; Rossanese, O.W.; Hoelder, S.; Burke, R.; van Montfort, R.L.M. Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays. Sci. Rep., 2022, 12(1), 18633. doi: 10.1038/s41598-022-23264-z PMID: 36329085Honisch, C.; Donadello, V.; Hussain, R.; Peterle, D.; De Filippis, V.; Arrigoni, G.; Gatto, C.; Giurgola, L.; Siligardi, G.; Ruzza, P. Application of circular dichroism and fluorescence spectroscopies to assess photostability of water-soluble porcine lens proteins. ACS Omega, 2020, 5(8), 4293-4301. doi: 10.1021/acsomega.9b04234 PMID: 32149259Böhm, G.; Muhr, R.; Jaenicke, R. Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng. Des. Sel., 1992, 5(3), 191-195. doi: 10.1093/protein/5.3.191 PMID: 1409538Pelton, J.T.; McLean, L.R. Spectroscopic methods for analysis of protein secondary structure. Anal. Biochem., 2000, 277(2), 167-176. doi: 10.1006/abio.1999.4320 PMID: 10625503Hawe, A.; Sutter, M.; Jiskoot, W. Extrinsic fluorescent dyes as tools for protein characterization. Pharm. Res., 2008, 25(7), 1487-1499. doi: 10.1007/s11095-007-9516-9 PMID: 18172579Wang, H.; Nakata, E.; Hamachi, I. Recent progress in strategies for the creation of protein-based fluorescent biosensors. ChemBioChem, 2009, 10(16), 2560-2577. doi: 10.1002/cbic.200900249 PMID: 19693761Hashemi-Shahraki, F.; Shareghi, B.; Farhadian, S. Characterizing the binding affinity and molecular interplay between quinoline yellow and pepsin. J. Mol. Liq., 2021, 341, 117317. doi: 10.1016/j.molliq.2021.117317Shakya, T.; Stogios, P.J.; Waglechner, N.; Evdokimova, E.; Ejim, L.; Blanchard, J.E.; McArthur, A.G.; Savchenko, A.; Wright, G.D. A small molecule discrimination map of the antibiotic resistance kinome. Chem. Biol., 2011, 18(12), 1591-1601. doi: 10.1016/j.chembiol.2011.10.018 PMID: 22195561Wybenga-Groot, Leanne E; Kari-ann, Draker Gerard D Wright, and Albert M Berghuis Crystal structure of an aminoglycoside 6′-N-acetyltransferase: defining the GCN5-related N-acetyltransferase superfamily fold In: Structure; Elsevier, 1999; pp. 497-507.Vetting, M.W.; Hegde, S.S.; Javid-Majd, F.; Blanchard, J.S.; Roderick, S.L. Aminoglycoside 2′-N-acetyltransferase from Mycobacterium tuberculosis in complex with coenzyme A and aminoglycoside substrates. Nat. Struct. Biol., 2002, 9(9), 653-658. doi: 10.1038/nsb830 PMID: 12161746Wolf, E.; Vassilev, A.; Makino, Y.; Sali, A.; Nakatani, Y.; Burley, S.K. Crystal structure of a GCN5-related N-acetyltransferase: Serratia marcescens aminoglycoside 3-N-acetyltransferase. Cell, 1998, 94(4), 439-449. doi: 10.1016/S0092-8674(00)81585-8 PMID: 9727487Benveniste, Raoul; Davies, Julian R‐factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics. In: FEBS letters; Wiley Online Library, 1971; pp. 293-296. doi: 10.1016/0014-5793(71)80282-XPendleton, Jack N Sean P Gorman, and Brendan F Gilmore Clinical relevance of the ESKAPE pathogens. In: Expert review of anti-infective therapy; Taylor & Francis, 2013; pp. 297-308.Jiang, M.; Kuang, S.; Lai, S.; Zhang, S.; Yang, J.; Peng, B.; Peng, X.; Chen, Z.; Li, H. Na + -NQR confers aminoglycoside resistance via the regulation of L- Alanine Metabolism. MBio, 2020, 11(6), e02086-20. doi: 10.1128/mBio.02086-20 PMID: 33203750Mingeot-Leclercq, M.P.; Glupczynski, Y.; Tulkens, P.M. Aminoglycosides: Activity and resistance. Antimicrob. Agents Chemother., 1999, 43(4), 727-737. doi: 10.1128/AAC.43.4.727 PMID: 10103173Ramazanzadeh, R.; Rouhi, S.; Shakib, P.; Shahbazi, B.; Bidarpour, F.; Karimi, M. Molecular characterization of vibrio cholerae isolated from clinical samples in kurdistan province, iran. Jundishapur J. Microbiol., 2015, 8(5), e18119. doi: 10.5812/jjm.8(4)2015.18102 PMID: 26060565Huth, M.E.; Ricci, A.J.; Cheng, A.G. Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. Int. J. Otolaryngol., 2011, 2011, 1-19. doi: 10.1155/2011/937861 PMID: 22121370Lv, B.; Bian, M.; Huang, X.; Sun, F.; Gao, Y.; Wang, Y.; Fu, Y.; Yang, B.; Fu, X. n -butanol potentiates subinhibitory aminoglycosides against bacterial persisters and multidrug-resistant mrsa by rapidly enhancing antibiotic uptake. ACS Infect. Dis., 2022, 8(2), 373-386. doi: 10.1021/acsinfecdis.1c00559 PMID: 35100802Altschul, S.F.; Madden, T.L.; Schäffer, A.A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D.J. Antimicrobial Resistance in ESKAPE Pathogens. Mol. Cell. Endocrinol., 1997, 246.Hishinuma, A.; Yoshida, A.; Suzuki, H.; Okuzumi, K.; Ishida, T. Complete sequencing of an IncFII NDM-1 plasmid in Klebsiella pneumoniae shows structural features shared with other multidrug resistance plasmids. J. Antimicrob. Chemother., 2013, 68(10), 2415-2417. doi: 10.1093/jac/dkt190 PMID: 23681270Bennett, P.M. Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br. J. Pharmacol., 2008, 153(S1)(Suppl. 1), S347-S357. doi: 10.1038/sj.bjp.0707607 PMID: 18193080Jiang, Z.; Wei, J.; Liang, Y.; Peng, N.; Li, Y. Aminoglycoside antibiotics inhibit mycobacteriophage infection. Antibiotics, 2020, 9(10), 714. doi: 10.3390/antibiotics9100714 PMID: 33086520Glinka, M.; Wojnowski, W.; Wasik, A. Determination of aminoglycoside antibiotics: Current status and future trends. Trends Analyt. Chem., 2020, 131, 116034. doi: 10.1016/j.trac.2020.116034Hitchcock, N.M.; Devequi, G.N.D.; Shiach, J.; Valeria, S.H.K.; Dantas, V.B.J.; Alencar, P.R.L.; Coler, B.S.; Botelho, P.S.M.; Badaró, R. Current clinical landscape and global potential of bacteriophage therapy. Viruses, 2023, 15(4), 1020. doi: 10.3390/v15041020 PMID: 37113000González-Bello, C.; Rodríguez, D.; Pernas, M.; Rodríguez, Á.; Colchón, E. β-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs. J. Med. Chem., 2020, 63(5), 1859-1881. doi: 10.1021/acs.jmedchem.9b01279 PMID: 31663735Bush, K. Synergistic antibiotic combinations. Antibacterials, 2017, 69-88. doi: 10.1007/7355_2017_23Schmitz, F.J.; Fluit, A.C.; Gondolf, M.; Beyrau, R.; Lindenlauf, E.; Verhoef, J.; Heinz, H.P.; Jones, M.E. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. J. Antimicrob. Chemother., 1999, 43(2), 253-259. doi: 10.1093/jac/43.2.253 PMID: 11252331Coia, J.E.; Duckworth, G.J.; Edwards, D.I.; Farrington, M.; Fry, C.; Humphreys, H.; Mallaghan, C.; Tucker, D.R. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J. Hosp. Infect., 2006, 63(Suppl. 1), S1-S44. doi: 10.1016/j.jhin.2006.01.001 PMID: 16581155Cox, G.; Ejim, L.; Stogios, P.J.; Koteva, K.; Bordeleau, E.; Evdokimova, E.; Sieron, A.O.; Savchenko, A.; Serio, A.W.; Krause, K.M.; Wright, G.D. Plazomicin retains antibiotic activity against most aminoglycoside modifying enzymes. ACS Infect. Dis., 2018, 4(6), 980-987. doi: 10.1021/acsinfecdis.8b00001 PMID: 29634241Sonousi, A.S.M. Synthesis of netilmicin and apramycin derivatives for the treatment of multidrug-resistant. Infect. Dis., 2017.Iyer, A.; Madder, A.; Singh, I. Teixobactins: A new class of 21st century antibiotics to combat multidrug-resistant bacterial pathogens. Future Microbiology; Future Medicine, 2019.Lebeis, S.L.; Kalman, D. Aligning antimicrobial drug discovery with complex and redundant host-pathogen interactions. Cell Host Microbe, 2009, 5(2), 114-122. doi: 10.1016/j.chom.2009.01.008 PMID: 19218083Mohloding, M. Expression, purification, and structure-function studies of recombinant Klebsiella pneumoniae aminoglycoside (3") (9) adenylyl transferase; University of the Witwatersrand, 2022.National Academies of Sciences and Medicine. Engineering In: Global health and the future role of the United States; National Academies Press, 2017.Carnahan, J. Unexpected: Finding Resilience through Functional Medicine, Science, and Faith; Simon and Schuster, 2023.